Dr. Lance L. Stein, MD

Dr. Stein practices at Piedmont Atlanta in Atlanta, Georgia, part of Piedmont Healthcare.

Dr. Stein's NPI, 1568558062, was assigned on October 4, 2006. Dr. Stein graduated from Temple University School of Medicine in 2003. Dr. Stein holds Georgia license 56368.

Dr. Stein's primary practice is Piedmont Atlanta, at 1968 Peachtree Rd NW, Atlanta, GA 30309 in Fulton County. The practice phone is (404) 605-5000.

Dr. Stein's primary practice is Piedmont Atlanta in Atlanta, Georgia, part of Piedmont Healthcare. Dr. Stein is also affiliated with Piedmont Athens Regional. The medical group on file is Piedmont Physicians Obstetrics and Gynecology of Jasper. Dmand AI also links Dr. Stein to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stein practices, 5 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Stein's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Stein is licensed in Georgia.

CMS data shows 337 Medicare services from Dr. Stein across 8 procedure codes in 2024, for 211 Medicare patients. Medicare paid $25,002 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 211 Medicare patients who saw Dr. Stein in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stein's median patient age at 58, with 55% women.

In 2024, Dr. Stein wrote 1,564 Medicare Part D claims for 260 patients. 82% of them were for generic drugs. CMS names the drug for 1,333 of them, across 30 drugs with 11 or more claims each, at $1,003,149 in total drug cost. In 2023, CMS named 1,224 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Stein for performance year 2024, reported through an alternative payment model (APM). Dr. Stein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stein as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Stein, published from 2011 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Acute-On-Chronic Liver Failure, Liver Neoplasms and Liver Transplantation. Dr. Stein has published most often in Liver Transpl. Dr. Stein's most frequent co-authors are Raymond A. Rubin, MD, Aravind Arepally, MD and Brett Emerson Fortune, MD.

Dmand AI links Dr. Stein to 4 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Hepatic Encephalopathy, Liver Cirrhosis and Liver Cirrhosis, Biliary.

CMS Open Payments shows 1,293 general payments to Dr. Stein from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Intercept Pharmaceuticals, Inc. paid the most, $305,883.

Dr. Stein graduated from Temple University School of Medicine in 2003.